Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VISMODEGIB, with a corresponding US DMF Number 41869.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 03, 2025, and payment made on July 03, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II